TWIST1 knockdown in ALK+ ALCL cell lines reduced their invasiveness and enhanced their sensitivity to an ALK inhibitor, suggesting TWIST1 may contribute to therapeutic resistance (174). Here, TWIST1 is linked to anaplastic large cell lymphoma.